New Tuberculosis Drug Regimen Will Move to Landmark Phase 3 Clinical Trial
Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both
News
News
TB Alliance Grants Fosun Pharma Rights to Develop, Market Promising TB Cure in China
TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that
News
TB Alliance and University of Stellenbosch Announce Launch of Study to Determine Proper TB Treatment for Babies with TB
TB Alliance, an international non-profit working to develop improved TB treatments, and the Desmond Tutu TB Center, an academic research
News
TB Alliance Establishes Advisory Group to Help End Neglect of Children with TB and Get Desperately-needed TB Medicines to Children
TB Alliance, an international non-profit that develops better, faster-acting, and affordable tuberculosis (TB) drugs, announced today the establishment of an
News
TB Alliance Launches Web Portal for Childhood Tuberculosis
TB Alliance today announced the launch of its new web portal (www.tballiance.org/children) which seeks to bridge an information gap that
News
TB Alliance Spins-out Non-TB Assets to TenNor Therapeutics
NEW YORK, NY – TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB)
News
New Collaboration Will Develop, Deliver Needed Childhood TB Medicines
30 October 2013 (PARIS, FRANCE): In an effort to develop and deliver treatments for children with tuberculosis (TB)—answering a critical
News
DFID Supports Development of New TB Cures
New York, USA: TB Alliance has received a grant from the United Kingdom’s Department for International Development (DFID) to support
News
AusAID Commits Support to TB Alliance to Advance New TB Drugs
New York, USA: The Global Alliance for TB Drug Development (TB Alliance) has received a grant from the Australian Agency
News
GHIT Leverages Japanese Innovation in Fight Against TB
The Global Health Innovative Technology Fund (GHIT Fund), a new public-private partnership that’s bringing Japanese research and development (R&D) to